Question: What is another name for the blood disorder Emmanuel Ntima Weyi founded a non-profit in support of?

Context paragraphs:
Emmanuel Weyi: Emmanuel Ntima Weyi is a Congolese entrepreneur and presidential candidate for the Democratic Republic of Congo.  He served as the Co-founder and Chief Executive Officer of Groupe Weyi International – a sustainable mining and renewable energy enterprise focused on the Congo from 2009-2014.  He also founded the Colorado Sickle Cell Foundation, a non-profit organization focused on bringing awareness to sufferers of sickle-cell anemia.

Cooley's Anemia Foundation: The Cooley’s Anemia Foundation (CAF) is an American 501(c)3 nonprofit organization which funds medical research and education to benefit individuals living with the genetic blood disorder, thalassemia.  The major form of this disorder is also known as Cooley's anemia.

LentiGlobin BB305: LentiGlobin BB305 is an experimental treatment for beta thalassemia, a rare and potentially debilitating blood disorder.  It is being developed by Bluebird Bio and was given “breakthrough therapy” designation by the Food and Drug Administration in February, 2015.  In early clinical trials several patients with beta thalassemia, who usually require frequent blood transfusions to treat their disease, were able to forgo blood transfusions for extended periods of time.

Not of This Earth (1957 film): Not of This Earth is an independently made 1957 American black-and-white science fiction film produced and directed by Roger Corman for his Los Altos Productions, that stars Paul Birch, Beverly Garland, Morgan Jones, William Roerick, and Anna Lee Carroll.  The film was written by Charles B. Griffith and Mark Hanna and was distributed by Allied Artists Pictures Corporation.  The film ran 67-minutes, expanded to 70 minutes for TV syndication in 1962.  The plot concerns the attempts by an extraterrestrial humanoid to surreptitiously secure the blood of Earth people and test it on himself in treatment of a fatal blood disorder which is ravaging his home planet, Davanna.

Hereditary elliptocytosis: Hereditary elliptocytosis, also known as ovalocytosis, is an inherited blood disorder in which an abnormally large number of the patient's erythrocytes (i.e. red blood cells) are elliptical rather than the typical biconcave disc shape.  Such morphologically distinctive erythrocytes are sometimes referred to as elliptocytes or ovalocytes.  It is one of many red-cell membrane defects.  In its severe forms, this disorder predisposes to haemolytic anaemia.  Although pathological in humans, elliptocytosis is normal in camelids.

Sickle-cell disease: Sickle-cell disease (SCD) is a group of blood disorders typically inherited from a person's parents.  The most common type is known as sickle-cell anaemia (SCA).  It results in an abnormality in the oxygen-carrying protein haemoglobin (hemoglobin S) found in red blood cells.  This leads to a rigid, sickle-like shape under certain circumstances.  Problems in sickle cell disease typically begin around 5 to 6 months of age.  A number of health problems may develop, such as attacks of pain ("sickle-cell crisis"), anemia, swelling in the hands and feet, bacterial infections, and stroke.  Long term pain may develop as people get older.  The average life expectancy in the developed world is 40 to 60 years.

Congenital dyserythropoietic anemia: Congenital dyserythropoietic anemia (CDA) is a rare blood disorder, similar to the thalassemias. CDA is one of many types of anemia, characterized by ineffective erythropoiesis, and resulting from a decrease in the number of red blood cells (RBCs) in the body and a less than normal quantity of hemoglobin in the blood.

Management of thalassemia: Treatment of the inherited blood disorder thalassemia depends upon the level of severity.  For mild forms of the condition, advice and counseling are often all that are necessary.  For more severe forms, treatment may consist in blood transfusion; chelation therapy to reverse iron overload, using drugs such as deferoxamine, deferiprone, or deferasirox; medication with the antioxidant indicaxanthin to prevent the breakdown of hemoglobin; or a bone marrow transplant using material from a compatible donor, or from the patient's mother.  Population screening has had some success as a preventive measure.

Hypoprothrombinemia: Hypoprothrombinemia is a blood disorder in which a deficiency of prothrombin (Factor II) results in impaired blood clotting, leading to an increased physiological risk for bleeding, especially in the gastrointestinal system, cranial vault, and superficial integumentary system.

Wisemen (rap group): The Wisemen is a hip hop group formed by Wu-Tang Clan affiliate Bronze Nazareth (who is one of the newest and most-heralded Wu-Tang affiliates) and his brother, the lyricist and producer Kevlaar 7.  However Kevlaar 7 died on December 23, 2014 from blood disorder.

Supporting paragraphs: Emmanuel Weyi Sickle-cell disease
Answer: Sickle-cell disease